Knowledge Base

🧬 Introduction Ivermectin, a well-known antiparasitic drug widely used to treat parasitic infections such as onchocerciasis and strongyloidiasis, has unexpectedly emerged as a candidate for cancer research. Over the past few years, scientific curiosity has grown around Ivermectin’s potential anti-cancer effects, spurred by promising preclinical data. Though not yet a part of mainstream oncology, Ivermectin